These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 17716297)

  • 1. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
    Harvie M; Howell A
    Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
    Healy LA; Ryan AM; Carroll P; Ennis D; Crowley V; Boyle T; Kennedy MJ; Connolly E; Reynolds JV
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):281-8. PubMed ID: 20189371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
    Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
    Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.
    Schäffler A; Schölmerich J; Buechler C
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):345-54. PubMed ID: 17377617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer.
    Carroll PA; Healy L; Lysaght J; Boyle T; Reynolds JV; Kennedy MJ; Pidgeon G; Connolly EM
    Mol Carcinog; 2011 Aug; 50(8):643-51. PubMed ID: 21574190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
    Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
    Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity on breast cancer development.
    Cleary MP; Grossmann ME; Ray A
    Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, adipokines, and prostate cancer (review).
    Baillargeon J; Rose DP
    Int J Oncol; 2006 Mar; 28(3):737-45. PubMed ID: 16465380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and breast cancer risk.
    Sinagra D; Amato C; Scarpilta AM; Brigandì M; Amato M; Saura G; Latteri MA; Caimi G
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):55-9. PubMed ID: 12708611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.